Gongwin Biopharm Holdings Co., Ltd. - 6617.TWO - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	1	1	1	19	32	36	42	📊
Revenue Growth (1Y)	--	+235.89%	+37.21%	0.00%	+1554.86%	+69.39%	+13.75%	+15.85%	📊
Revenue Growth (5Y)	--	--	--	--	+7527.02%	+3746.34%	+3088.63%	+3594.14%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	0	0	0	0	8	23	21	32	📊
Cost of Revenue Growth (1Y)	--	+235.71%	+38.30%	+18.46%	+9919.48%	+202.79%	-8.13%	+50.66%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+55007.14%	+49602.13%	+32915.38%	+49641.54%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	0	1	1	1	11	9	15	10	📊
Gross Profit Growth (1Y)	--	+235.90%	+37.15%	-1.11%	+950.66%	-22.50%	+72.65%	-33.99%	📊
Gross Profit Growth (5Y)	--	--	--	--	+4686.32%	+1004.33%	+1290.17%	+817.63%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	129	118	122	262	145	171	222	250	📊
Operating Expenses Growth (1Y)	--	-8.45%	+3.18%	+114.72%	-44.78%	+18.14%	+30.19%	+12.62%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+11.99%	+44.51%	+82.34%	+105.34%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	47	42	39	67	92	102	116	136	📊
Research and Development	83	76	83	194	53	63	119	126	📊
Other Income Expenses	0	0	0	0	0	6	-13	-12	📊
EBITDA	-102	-86	-101	-276	-81	-77	-196	-281	📊
EBITDA Growth (1Y)	--	+15.29%	-16.57%	-173.97%	+70.59%	+5.50%	-156.16%	-43.34%	📊
EBITDA Growth (5Y)	--	--	--	--	+20.44%	+11.24%	-95.05%	-179.58%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	6	13	13	13	13	11	11	11	📊
Operating Income	-129	-99	-114	-289	-133	-162	-207	-242	📊
Operating Income Growth (1Y)	--	+23.29%	-14.90%	-154.49%	+53.86%	-21.55%	-27.91%	-16.87%	📊
Operating Income Growth (5Y)	--	--	--	--	-3.50%	-64.00%	-82.57%	-113.38%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	1	1	1	3	7	4	5	4	📊
Pre Tax Income	-115	-99	-115	-292	-101	-92	-121	-176	📊
Tax Provision	0	-6	15	-38	0	0	0	--	📊
NET INCOME	-110	-93	-122	-254	-92	-83	-114	-165	📊
Net Income Growth (1Y)	--	+15.25%	-30.63%	-109.07%	+63.79%	+10.31%	-38.25%	-44.15%	📊
Net Income Growth (5Y)	--	--	--	--	+16.20%	+11.31%	+6.13%	-35.32%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	-1.07	-0.88	-1.1	-2.29	-0.81	-0.68	-0.92	-1.35	📊
Diluted EPS	-1.07	-0.88	-1.1	-2.29	-0.81	-0.68	-0.92	-1.35	📊
Basic Average Shares	103	106	111	111	114	121	123	122	📊
Diluted Average Shares	103	106	111	111	113	121	123	122	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

+235.89%

+37.21%

0.00%

+1554.86%

+69.39%

+13.75%

+15.85%

📊

Revenue Growth (5Y)

+7527.02%

+3746.34%

+3088.63%

+3594.14%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

+235.71%

+38.30%

+18.46%

+9919.48%

+202.79%

-8.13%

+50.66%

📊

Cost of Revenue Growth (5Y)

+55007.14%

+49602.13%

+32915.38%

+49641.54%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

📊

Gross Profit Growth (1Y)

+235.90%

+37.15%

-1.11%

+950.66%

-22.50%

+72.65%

-33.99%

📊

Gross Profit Growth (5Y)

+4686.32%

+1004.33%

+1290.17%

+817.63%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

129

118

122

262

145

171

222

250

📊

Operating Expenses Growth (1Y)

-8.45%

+3.18%

+114.72%

-44.78%

+18.14%

+30.19%

+12.62%

📊

Operating Expenses Growth (5Y)

+11.99%

+44.51%

+82.34%

+105.34%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

102

116

136

📊

Research and Development

194

119

126

📊

Other Income Expenses

-13

-12

📊

EBITDA

-102

-86

-101

-276

-81

-77

-196

-281

📊

EBITDA Growth (1Y)

+15.29%

-16.57%

-173.97%

+70.59%

+5.50%

-156.16%

-43.34%

📊

EBITDA Growth (5Y)

+20.44%

+11.24%

-95.05%

-179.58%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-129

-99

-114

-289

-133

-162

-207

-242

📊

Operating Income Growth (1Y)

+23.29%

-14.90%

-154.49%

+53.86%

-21.55%

-27.91%

-16.87%

📊

Operating Income Growth (5Y)

-3.50%

-64.00%

-82.57%

-113.38%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-115

-99

-115

-292

-101

-92

-121

-176

📊

Tax Provision

-6

-38

📊

NET INCOME

-110

-93

-122

-254

-92

-83

-114

-165

📊

Net Income Growth (1Y)

+15.25%

-30.63%

-109.07%

+63.79%

+10.31%

-38.25%

-44.15%

📊

Net Income Growth (5Y)

+16.20%

+11.31%

+6.13%

-35.32%

📊

Net Income Growth (10Y)

📊

Basic EPS

-1.07

-0.88

-1.1

-2.29

-0.81

-0.68

-0.92

-1.35

📊

Diluted EPS

-1.07

-0.88

-1.1

-2.29

-0.81

-0.68

-0.92

-1.35

📊

Basic Average Shares

103

106

111

114

121

123

122

📊

Diluted Average Shares

103

106

111

113

121

123

122

📊

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	1	1	1	19	32	36	42	📊
Revenue Growth (1Y)	--	+235.89%	+37.21%	0.00%	+1554.86%	+69.39%	+13.75%	+15.85%	📊
Revenue Growth (5Y)	--	--	--	--	+7527.02%	+3746.34%	+3088.63%	+3594.14%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	0	0	0	0	8	23	21	32	📊
Cost of Revenue Growth (1Y)	--	+235.71%	+38.30%	+18.46%	+9919.48%	+202.79%	-8.13%	+50.66%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+55007.14%	+49602.13%	+32915.38%	+49641.54%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	0	1	1	1	11	9	15	10	📊
Gross Profit Growth (1Y)	--	+235.90%	+37.15%	-1.11%	+950.66%	-22.50%	+72.65%	-33.99%	📊
Gross Profit Growth (5Y)	--	--	--	--	+4686.32%	+1004.33%	+1290.17%	+817.63%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	129	118	122	262	145	171	222	250	📊
Operating Expenses Growth (1Y)	--	-8.45%	+3.18%	+114.72%	-44.78%	+18.14%	+30.19%	+12.62%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+11.99%	+44.51%	+82.34%	+105.34%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	47	42	39	67	92	102	116	136	📊
Research and Development	83	76	83	194	53	63	119	126	📊
Other Income Expenses	0	0	0	0	0	6	-13	-12	📊
EBITDA	-102	-86	-101	-276	-81	-77	-196	-281	📊
EBITDA Growth (1Y)	--	+15.29%	-16.57%	-173.97%	+70.59%	+5.50%	-156.16%	-43.34%	📊
EBITDA Growth (5Y)	--	--	--	--	+20.44%	+11.24%	-95.05%	-179.58%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	6	13	13	13	13	11	11	11	📊
Operating Income	-129	-99	-114	-289	-133	-162	-207	-242	📊
Operating Income Growth (1Y)	--	+23.29%	-14.90%	-154.49%	+53.86%	-21.55%	-27.91%	-16.87%	📊
Operating Income Growth (5Y)	--	--	--	--	-3.50%	-64.00%	-82.57%	-113.38%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	1	1	1	3	7	4	5	4	📊
Pre Tax Income	-115	-99	-115	-292	-101	-92	-121	-176	📊
Tax Provision	0	-6	15	-38	0	0	0	--	📊
NET INCOME	-110	-93	-122	-254	-92	-83	-114	-165	📊
Net Income Growth (1Y)	--	+15.25%	-30.63%	-109.07%	+63.79%	+10.31%	-38.25%	-44.15%	📊
Net Income Growth (5Y)	--	--	--	--	+16.20%	+11.31%	+6.13%	-35.32%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	-1.07	-0.88	-1.1	-2.29	-0.81	-0.68	-0.92	-1.35	📊
Diluted EPS	-1.07	-0.88	-1.1	-2.29	-0.81	-0.68	-0.92	-1.35	📊
Basic Average Shares	103	106	111	111	114	121	123	122	📊
Diluted Average Shares	103	106	111	111	113	121	123	122	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

+235.89%

+37.21%

0.00%

+1554.86%

+69.39%

+13.75%

+15.85%

📊

Revenue Growth (5Y)

+7527.02%

+3746.34%

+3088.63%

+3594.14%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

+235.71%

+38.30%

+18.46%

+9919.48%

+202.79%

-8.13%

+50.66%

📊

Cost of Revenue Growth (5Y)

+55007.14%

+49602.13%

+32915.38%

+49641.54%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

📊

Gross Profit Growth (1Y)

+235.90%

+37.15%

-1.11%

+950.66%

-22.50%

+72.65%

-33.99%

📊

Gross Profit Growth (5Y)

+4686.32%

+1004.33%

+1290.17%

+817.63%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

129

118

122

262

145

171

222

250

📊

Operating Expenses Growth (1Y)

-8.45%

+3.18%

+114.72%

-44.78%

+18.14%

+30.19%

+12.62%

📊

Operating Expenses Growth (5Y)

+11.99%

+44.51%

+82.34%

+105.34%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

102

116

136

📊

Research and Development

194

119

126

📊

Other Income Expenses

-13

-12

📊

EBITDA

-102

-86

-101

-276

-81

-77

-196

-281

📊

EBITDA Growth (1Y)

+15.29%

-16.57%

-173.97%

+70.59%

+5.50%

-156.16%

-43.34%

📊

EBITDA Growth (5Y)

+20.44%

+11.24%

-95.05%

-179.58%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-129

-99

-114

-289

-133

-162

-207

-242

📊

Operating Income Growth (1Y)

+23.29%

-14.90%

-154.49%

+53.86%

-21.55%

-27.91%

-16.87%

📊

Operating Income Growth (5Y)

-3.50%

-64.00%

-82.57%

-113.38%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-115

-99

-115

-292

-101

-92

-121

-176

📊

Tax Provision

-6

-38

📊

NET INCOME

-110

-93

-122

-254

-92

-83

-114

-165

📊

Net Income Growth (1Y)

+15.25%

-30.63%

-109.07%

+63.79%

+10.31%

-38.25%

-44.15%

📊

Net Income Growth (5Y)

+16.20%

+11.31%

+6.13%

-35.32%

📊

Net Income Growth (10Y)

📊

Basic EPS

-1.07

-0.88

-1.1

-2.29

-0.81

-0.68

-0.92

-1.35

📊

Diluted EPS

-1.07

-0.88

-1.1

-2.29

-0.81

-0.68

-0.92

-1.35

📊

Basic Average Shares

103

106

111

114

121

123

122

📊

Diluted Average Shares

103

106

111

113

121

123

122

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	0.83%
Next Earnings	--
Market cap	17.32B (TWD)
EPS (TTM)	-1.35 (TWD)
P/E (TTM)	-105.93 (TWD)
Last Close	143.00

Next Earnings	--
Market cap	17.32B (TWD)
EPS (TTM)	-1.35 (TWD)
P/E (TTM)	-105.93 (TWD)
Last Close	143.00 (TWD)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	0.83%
Next Earnings	--
Market cap	17.32B (TWD)
EPS (TTM)	-1.35 (TWD)
P/E (TTM)	-105.93 (TWD)
Last Close	143.00

Next Earnings	--
Market cap	17.32B (TWD)
EPS (TTM)	-1.35 (TWD)
P/E (TTM)	-105.93 (TWD)
Last Close	143.00 (TWD)